Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we submit herewith the consolidated Scrutinizer s Report of the votes castthrough electronic voting and electronic polling process conducted during the 74th AnnualGeneral Meeting of the Company held on Monday, July 21, 2025 at 3.00 p.m. (IST)
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Limited submitted the consolidated scrutinizer's report for voting at its 74th AGM, where all five ordinary resolutions were passed with overwhelming majority. A dividend of Rs. 165 per share (1650%) for FY ending March 31, 2025 was approved, along with adoption of audited financial statements, re-appointment of Mr. Amit Agarwal as Director, ratification of cost auditor remuneration, and appointment of M/s. Parikh & Associates as secretarial auditors. Out of 1,08,832 shareholders on record date, 56 attended via video conferencing, representing about 66% of capital. Voting turnout was around 83.8% of outstanding shares, with every resolution receiving more than 99.8% support from valid votes cast.
Shareholders get a robust dividend of Rs. 165 per share, a strong signal of cash returns. All governance resolutions sailed through smoothly, reflecting broad shareholder confidence with no meaningful dissent, which is neutral to mildly positive for the stock.